Related Experiment Videos
Phospholipid binding of antiphospholipid antibodies and placental anticoagulant protein
L R Sammaritano1, A E Gharavi, C Soberano
1Division of Rheumatic Diseases, Hospital for Special Surgery-Cornell University Medical Center, New York, New York 10021.
Abstract:
We evaluated the interaction of antiphospholipid antibodies (aPL) with placental anticoagulant protein I (PAP I), a calcium-dependent phospholipid binding protein which may act as a natural anticoagulant. Clotting assays showed additive prolongation of clotting times with aPL and PAP I. ELISA and vesicle phospholipid binding studies showed PAP I inhibition of aPL binding to phospholipid but no inhibition of PAP I-phospholipid binding by aPL. aPL and PAP I interact additively in anticoagulant activity in in vitro clotting systems and compete for phospholipid in ELISA system. These data support the hypotheses that aPL and PAP I may recognize similar phospholipid epitopes and that in vivo interaction may occur.